Target intelligence / Profile preview

TRPC6 pseudogene 4 (TRPC6P4)

Target
TRPC6P4
Molecular classification
Other (pseudogene)
01

Overview

TRPC6 pseudogene 4 (TRPC6P4) is a non-protein-coding pseudogene related to the TRPC6 gene family. Pseudogenes are segments of DNA resembling functional genes but are typically nonfunctional due to mutations, deletions, or insertions that prevent protein expression. Unlike the functional TRPC6 gene, which encodes a calcium-permeable ion channel implicated in podocyte biology, immune signaling, and cardiovascular disease, TRPC6P4 does not encode an active ion channel and is not considered a therapeutic or molecular target. While "TRPC6" refers to the *Transient receptor potential cation channel subfamily C member 6*—a well-studied ion channel and a bona fide therapeutic target in kidney and cardiovascular diseases[1][2][4][5][7]—the suffix “pseudogene 4” clearly indicates that TRPC6P4 represents a non-coding, likely non-functional genomic element. Pseudogenes are not classified as receptors, enzymes, transporters, transcription factors, or any conventional molecular target classes. There is no evidence in scientific literature or bioinformatics databases that TRPC6P4 has functional protein product, biological function, disease association, or interacts with drugs. Its presence in genomic annotations typically serves as a reference for evolutionary or transcriptomic studies rather than therapeutic development. TRPC6 pseudogene 4 (TRPC6P4) is not a molecular target and should not be considered for target-based research or drug development. “TRPC6” (without the pseudogene designation) is the canonical reference for the functional protein-coding gene and relevant therapeutic target.

Beyond the preview

Go deeper on TRPC6 pseudogene 4 (TRPC6P4).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on TRPC6 pseudogene 4 (TRPC6P4).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call